NCT05269680 STAR-LIFE: a Post-market Registry on MINIject
| NCT ID | NCT05269680 |
| Status | Recruiting |
| Phase | — |
| Sponsor | iSTAR Medical |
| Condition | Open Angle Glaucoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 750 participants |
| Start Date | 2022-07-20 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 750 participants in total. It began in 2022-07-20 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As part of the post-market clinical follow-up (PMCF), this registry is developed to ensure real-world data collection on MINIject device.
Eligibility Criteria
Inclusion Criteria: * 18+ years * diagnosed with open angle glaucoma, who has been or will be implanted with CE-marked MINIject * able to give consent Exclusion Criteria: * eyes with angle closure glaucoma * eyes with traumatic, malignant, uveitic or neovascular glaucoma or discernible congenital anomalies of the anterior chamber angle * patients with known intolerance or hypersensitivity to silicone * patients unable to give consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05269680 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Open Angle Glaucoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05269680 currently recruiting?
Yes, NCT05269680 is actively recruiting participants. Contact the research team at florence.defresne@istartmed.com for enrollment information.
Where is the NCT05269680 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT05269680 clinical trial?
NCT05269680 is sponsored by iSTAR Medical. The trial plans to enroll 750 participants.